Pharmaceutical research · 2026
In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tülümen Deniz, Aydemir Esra, Ayaz Furkan
Аннотация
BACKGROUND: Crimean-Congo hemorrhagic fever virus (CCHFV), identified by the World Health Organization(WHO) as a potential epidemic threat, is a tick-borne Nairovirus primarily transmitted by Hyalomma marginatum species. Since its first detection in the 1940s, CCHFV has spread to multiple regions worldwide and remains a major public health concern due to its high fatality rate and expanding geographic distribution. The virus can be transmitted through tick bites or contact with infected individuals, and no licensed vaccine is currently available to prevent infection.
METHODS: In this study, two CCHFV proteins, Q8JSZ3 (GP_CCHFI) and Q6TQR6 (L_CCHFI), were retrieved from public databases and analyzed using bioinformatic tools to explore their potential as vaccine candidates.
RESULTS: The computational analyses revealed that both proteins possess non-toxic characteristics and show promise for future vaccine design.
CONCLUSIONS: These findings provide a preliminary in-silico framework that may guide the development of effective vaccines against CCHFV.
METHODS: In this study, two CCHFV proteins, Q8JSZ3 (GP_CCHFI) and Q6TQR6 (L_CCHFI), were retrieved from public databases and analyzed using bioinformatic tools to explore their potential as vaccine candidates.
RESULTS: The computational analyses revealed that both proteins possess non-toxic characteristics and show promise for future vaccine design.
CONCLUSIONS: These findings provide a preliminary in-silico framework that may guide the development of effective vaccines against CCHFV.